Literature DB >> 22881038

Comparison of mini-open anterior corpectomy and posterior total en bloc spondylectomy for solitary metastases of the thoracolumbar spine.

Taolin Fang1, Jian Dong, Xiaogang Zhou, Robert A McGuire, Xilei Li.   

Abstract

OBJECT: The object of this study was to compare the mini-open anterior corpectomy procedure with posterior total en bloc spondylectomy (TES) in treating patients with solitary metastases of the thoracolumbar spine.
METHODS: From 2004 to 2010, 41 patients with solitary metastases of the thoracolumbar spine were treated in our hospital using either a mini-open anterior corpectomy or posterior TES. Intraoperative and diagnostic data, including perioperative complications, were collected using retrospective chart review. The surgical outcomes were assessed according to survival status, neurological function, local recurrence, and pain before and after surgery.
RESULTS: Seventeen patients underwent posterior TES and 24 underwent mini-open anterior corpectomy. Mean blood loss (TES, 1721 ± 293 ml; mini-open corpectomy, 1058 ± 263 ml; p < 0.05), and mean operative time (TES, 403 ± 55 minutes; mini-open corpectomy, 175 ± 38 minutes; p < 0.05) were recorded and calculated. Neurological improvement by at least 1 American Spinal Injury Association Impairment Scale grade was noted in 35 (97.2%) of the 36 cases with preoperative deficits. After the operation, 68.4% of nonambulatory patients became ambulatory again, including 84.6% after mini-open corpectomy and 33.3% after posterior TES (p > 0.05). The visual analog scale scores of the patients were significantly reduced after both procedures, with no difference between the procedures (p > 0.05). The local tumor recurrence rate of the TES group was significantly lower than that of the mini-open corpectomy group (p < 0.05), while the postoperative survival rates within 2 years after surgery were similar. The complication rate in the mini-open corpectomy group (29.2%) was higher than that in the TES group (11.8%), but this difference was not statistically significant (p = 0.185). There was no hardware failure and no loss of the sagittal Cobb angle in either group. Slight subsidence (< 3 mm) of the mesh cage was observed with a successful fusion in 3 (17.6%) of 17 patients in the TES group. No subsidence of polymethylmethacrylate block/autograft was recorded in the mini-open group.
CONCLUSIONS: Mini-open anterior corpectomy can be accomplished with less blood loss, fewer fixation instrumentations, and shorter surgical time than that required for TES, but patients who undergo a mini-open corpectomy might have a greater tendency to experience local recurrence. A mini-open anterior corpectomy has a relatively mild learning curve and involves fewer technical difficulties. With smaller incisions, mini-open anterior corpectomy is an option in treating solitary metastases of the thoracolumbar spine.

Entities:  

Mesh:

Year:  2012        PMID: 22881038     DOI: 10.3171/2012.7.SPINE111086

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  11 in total

Review 1.  Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence.

Authors:  Zach Pennington; A Karim Ahmed; Camilo A Molina; Jeffrey Ehresman; Ilya Laufer; Daniel M Sciubba
Journal:  Ann Transl Med       Date:  2018-03

Review 2.  Thoracolumbar corpectomy/spondylectomy for spinal metastasis: a pooled analysis comparing the outcome of seven different surgical approaches.

Authors:  Alexander Spiessberger; Varun Arvind; Basil Gruter; Samuel K Cho
Journal:  Eur Spine J       Date:  2019-10-22       Impact factor: 3.134

3.  Recurrent adamantinoma in the thoracolumbar spine successfully treated by three-level total en bloc spondylectomy by a single posterior approach.

Authors:  Ping-Guo Duan; Ruo-Yu Li; Yun-Qi Jiang; Hui-Ren Wang; Xiao-Gang Zhou; Xi-Lei Li; Yi-Chao Wang; Jian Dong
Journal:  Eur Spine J       Date:  2014-10-22       Impact factor: 3.134

Review 4.  Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities.

Authors:  Alfredo Conti; Güliz Acker; Anne Kluge; Franziska Loebel; Anita Kreimeier; Volker Budach; Peter Vajkoczy; Ilaria Ghetti; Antonino F Germano'; Carolin Senger
Journal:  Front Oncol       Date:  2019-09-19       Impact factor: 6.244

5.  Strategies for posterior-only minimally invasive surgery in thoracolumbar metastatic epidural spinal cord compression.

Authors:  Mohammed Abdul Alshareef; Gibson Klapthor; Stephen R Lowe; Jessica Barley; David Cachia; Bruce M Frankel
Journal:  Surg Neurol Int       Date:  2020-12-22

6.  Comprehensive surgical treatment strategy for spinal metastases.

Authors:  Arthur Wagner; Elena Haag; Ann-Kathrin Joerger; Philipp Jost; Stephanie E Combs; Maria Wostrack; Jens Gempt; Bernhard Meyer
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

7.  Comparison of Minimally Invasive Tubular Surgery with Conventional Surgery in the Treatment of Thoracolumbar Metastasis.

Authors:  Yunpeng Cui; Xuedong Shi; Chuan Mi; Bing Wang; Yuanxing Pan; Yunfei Lin
Journal:  Cancer Manag Res       Date:  2021-11-09       Impact factor: 3.989

Review 8.  Surgical Metastasectomy in the Spine: A Review Article.

Authors:  Satoshi Kato; Satoru Demura; Kazuya Shinmura; Noriaki Yokogawa; Takaki Shimizu; Hideki Murakami; Norio Kawahara; Katsuro Tomita; Hiroyuki Tsuchiya
Journal:  Oncologist       Date:  2021-06-12

Review 9.  When Less Is More: The indications for MIS Techniques and Separation Surgery in Metastatic Spine Disease.

Authors:  Scott L Zuckerman; Ilya Laufer; Arjun Sahgal; Yoshiya J Yamada; Meic H Schmidt; Dean Chou; John H Shin; Naresh Kumar; Daniel M Sciubba
Journal:  Spine (Phila Pa 1976)       Date:  2016-10-15       Impact factor: 3.241

10.  Is Less Really More? Economic Evaluation of Minimally Invasive Surgery.

Authors:  Andrew S Chung; Alexander Ballatori; Brandon Ortega; Elliot Min; Blake Formanek; John Liu; Patrick Hsieh; Raymond Hah; Jeffrey C Wang; Zorica Buser
Journal:  Global Spine J       Date:  2020-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.